The pyrin family of fever genes: Unmasking genetic determinants of autoinflammatory disease

Archives of Dermatology

Volumn 141, Issue 2, 2005, Pages 242-247

  Shinkai, Kanade ^b   Kilcline, Christine ^b   Connolly, M Kari ^b   Frieden, Ilona J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; COLD INDUCED AUTOINFLAMMATORY SYNDROME 1 PROTEIN; CRYOPYRIN; PROTEIN; PROTEIN MEFV; PYRIN; UNCLASSIFIED DRUG;

ACNE; BLAU SYNDROME; CHROMOSOME; CINCA SYNDROME; CLINICAL FEATURE; CROHN DISEASE; CYTOKINE PRODUCTION; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILIAL MEDITERRANEAN FEVER; FEVER; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENOME ANALYSIS; HEREDITY; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; INFLAMMATORY DISEASE; MOLECULAR RECOGNITION; MUCKLE WELLS SYNDROME; MULTIGENE FAMILY; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PYODERMA GANGRENOSUM; PYOGENIC STERILE ARTHRITIS; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

AUTOIMMUNE DISEASES; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 13444249533     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.2.242     Document Type: Note

References (62)

1. Kile RL, Rusk HA. A case of cold urticaria with unusual family history. JAMA. 1940;114:1067-1068.
2. Zip CM, Ross JB, Greaves MW, Scriver CR, Mitchell JJ, Zoar S. Familial cold urticaria. Clin Exp Dermatol. 1993;18:338-341.
3. Muckle TJ, Wells M. Urticaria, deafness and amyloidosis: a new heredo-familial syndrome. Q J Med. 1962;31:235-248.
4. Muckle TJ. The Muckle-Wells syndrome. Br J Dermatol. 1979;100:87-92.
5. Prieur AM, Griscelli C. Arthropathy with rash, chronic meningitis, neurological changes and arthritis. J Pediatr. 1981;99:79-83.
6. Prieur AM. A recently recognized chronic inflammatory disease of early onset characterized by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol. 2001;19:103-106.
7. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25-31.
8. International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797-807.
9. Siegal S. Benign paroxysmal peritonitis. Ann Intern Med. 1945;23:1-22.
10. Barakat MH, Karnik AM, Majeed HWA, El-Sobki NI, Fenech FF. Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs - a study of 175 patients and review of the literature. Q J Med. 1986;60:837-847.
11. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
12. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
13. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19-20.
14. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689-693.
15. Bouroncle BA, Doan CA. "Periodic fever": occurrence in five generations. Am J Med. 1957;23:502-506.
16. Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BHB, Toghill PJ. Familial Hibernian fever. Q J Med. 1982;51:469-480.
17. van der Meer JW, Vossen JM, Radl J, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984;1:1087-1090.
18. Drenth JP, Haagsma CJ, van der Meer JWM; International Hyper-IgD Study Group. Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. Medicine (Baltimore). 1994;73:133-144.
19. Wise C, Gillum J, Seidman C, et al. Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet. 2002;11:961-969.
20. Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc. 1997;72:611-615.
21. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol. 2003;15:61-69.
22. Fairbrother WJ, Gordon NC, Humke EW, et al. The PYRIN domain: a member of the death domain-fold superfamily. Protein Sci. 2001;10:1911-1918.
23. Mansfield E, Chae JJ, Komarow HD, et al. The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood. 2001;98:851-859.
24. Kilcline C, Shinkai K, Bree A, Modica R, Von Scheven E, Frieden IJ. Neonatal-onset multisystem inflammatory disorder: the emerging role of pyrin genes in autoinflammatory diseases. Arch Dermatol. 2005;141:248-253.
25. Pawlowski K, Pio F, Chu ZL, Reed JC, Godzik A. PAAD - a new protein domain associated with apoptosis, cancer, and autoimmune diseases. Trends Biochem Sci. 2001;26:85-87.
26. Tschopp J, Martinon F, Burns K. NALPS: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 2003;4:95-104.
27. Chamaillard M, Girardin S, Viala J, Philpott D. Nods, Nalps, and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol. 2003;5:581-592.
28. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104:487-501.
29. Reed JC, Doctor K, Rojas A, et al. Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res. 2003;13:1376-1388.
30. Fiorentino L, Stehlik C, Oliveira V, Ariza ME, Godzik A, Reed JC. A novel PAAD-containing protein that modulates NFκB induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J Biol Chem. 2002;277:35333-35340.
31. Manji GA, Wang L, Geddes BJ, et al. PYPAF1, a pyrin-containing Apaf1-like protein that assembles with ASC and regulates activation of NFkB. J Biol Chem. 2002;277:11570-11575.
32. Wang L, Manji G, Grenier J, et al. PYPAF7: a novel PYRIN-containing APAF1-like protein that regulates activation of NFκB and caspase-1-dependent cytokine processing. J Biol Chem. 2002;277:29874-29880.
33. Ghosh S, Karin M. Missing pieces in the NFκB puzzle. Cell. 2002;109:S81-S96.
34. Stehlik C, Fiorentino L, Dorfleutner A, et al. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappa B activation pathways. J Exp Med. 2002;196:1605-1615.
35. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang ZJ, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem. 2002;277:21119-21122.
36. Richards N, Schaner P, Diaz A, et al. Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J Biol Chem. 2001;276:39320-39329.
37. Hoffmann JA, Kafatos FC, Janeway CA Jr, Ezekowitz RAB. Phylogenetic perspectives in innate immunity. Science. 1999;284:1313-1318.
38. Gershoni-Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schonlein purpura. J Pediatr. 2003;143:658-661.
39. Chae JJ, Komarow H, Cheng J, et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell. 2003;11:591-604.
40. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002;10:417-426.
41. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319-325.
42. Dode C, Le Du N, Cuisset L, et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet. 2002;70:1498-1506.
43. Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002;71:198-203.
44. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and the Muckle-Wells syndrome. Nat Genet. 2001;29:301-305.
45. Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 2002;46:3340-3348.
46. Aganna E, Martinon F, Hawkins PN, et al. Association of mutations in the NALP3/CIAS1/ PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 2002;46:2445-2452.
47. Hoffman HM, Gregory SG, Mueller JL, et al. Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum Genet. 2003;112:209-216.
48. Huttenlocher A, Frieden IJ, Emery H. Case report: neonatal onset multisystem inflammatory disease. J Rheumatol. 1995;22:1171-1173.
49. Dowds TA, Masumoto J, Zhu L, Inohara N, Nunez G. Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J Biol Chem. 2004;279:21924-21928.
50. Smahi A, Courtois G, Rabia SH, et al. The NFκB signaling pathway in human diseases: from incontinentia pigmentito ectodermal dysplasias and immune-deficiency syndromes. Hum Mol Genet. 2002;11:2371-2375.
51. Pasparakis M, Courtois G, Hafner M, et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature. 2002;417:861-866.
52. Bell S, Degitz K, Quirling M, Jilg N, Page S, Brand K. Involvement of NF-kappaB signaling in skin physiology and disease. Cell Signal. 2003;15:1-7.
53. Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol. 2002;47:169-187.
54. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782-787.
55. Inohara N, Nunez G. Nods: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371-382.
56. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 2001;11:725-732.
57. Hurwitz D, Pincus L, Kupper T. Imiquimod: a topically applied link between innate and acquired immunity. Arch Dermatol. 2003;139:1347-1349.
58. Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol. 2003;139:1325-1332.
59. Hemmi H, Kaisho T, Takeuchi O, et al. Small antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3:196-200.
60. Koonin EV, Aravind L. The NACHT family - a new group of predicted NTPases implicated in apoptosis and MHC transcription activation. Trends Biochem Sci. 2000;25(5):223-224.
61. Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun. 2003;302:575-580.
62. Shoham N, Centola M, Mansfield E, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A. 2003;100:13501-13506.